These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 903369)

  • 1. The proliferative response of hepatic peroxidomes of neonatal rats to treatment with SU-13 437 (nafenopin).
    Stäubli W; Schweizer W; Suter J; Weibel ER
    J Cell Biol; 1977 Sep; 74(3):665-89. PubMed ID: 903369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
    Leighton F; Coloma L; Koenig C
    J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
    J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nafenopin-induced proliferation of peroxisomes in the small intestine of mice.
    Psenicnik M; Pipan N
    Virchows Arch B Cell Pathol; 1977 Oct; 25(2):161-9. PubMed ID: 412313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 6. Microperoxisomes and peroxisomes in relation to lipid metabolism.
    Novikoff AB; Novikoff PM
    Ann N Y Acad Sci; 1982; 386():138-52. PubMed ID: 6953844
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of peroxisomal enzymes in livers of neonatal rats exposed to lactating mothers treated with hypolipidaemic drugs. Role of drug metabolite transfer in milk.
    Fahl WE; Lalwani ND; Reddy MK; Reddy JK
    Biochem J; 1983 Mar; 210(3):875-83. PubMed ID: 6683505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.
    Reddy JK
    J Histochem Cytochem; 1973 Nov; 21(11):967-71. PubMed ID: 4587529
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset.
    Lake BG; Evans JG; Gray TJ; Körösi SA; North CJ
    Toxicol Appl Pharmacol; 1989 Jun; 99(1):148-60. PubMed ID: 2499080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
    Bieri F; Bentley P; Waechter F; Stäubli W
    Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term maintenance of hepatocytes in primary culture in the presence of DMSO: further characterization and effect of nafenopin, a peroxisome proliferator.
    Muakkassah-Kelly SF; Bieri F; Waechter F; Bentley P; Stäubli W
    Exp Cell Res; 1987 Jul; 171(1):37-51. PubMed ID: 3622636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
    Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
    Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peroxisome proliferation-associated polypeptide in rat liver.
    Reddy JK; Kumar NS
    Biochem Biophys Res Commun; 1977 Aug; 77(3):824-9. PubMed ID: 901515
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
    Conway JG; Neptun DA; Garvey LK; Popp JA
    Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348.
    Moody DE; Reddy JK
    J Cell Biol; 1976 Dec; 71(3):768-80. PubMed ID: 993270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased hepatotoxicity of carbon tetrachloride by the hypolipidemic drug nafenopin in rats.
    Charpentier D; Tuchweber B
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):449-61. PubMed ID: 6289397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin.
    Moody DE; Rao MS; Reddy JK
    Virchows Arch B Cell Pathol; 1977 Apr; 23(4):291-6. PubMed ID: 404752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of DNA synthesis but not of peroxisomal beta-oxidation by nafenopin in primary cultures of marmoset hepatocytes.
    Bieri F; Stäubli W; Waechter F; Muakkassah-Kelly S; Bentley P
    Cell Biol Int Rep; 1988 Dec; 12(12):1077-87. PubMed ID: 3147145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.